World Bank Probes Fraud, Corruption In Drug-Funded Projects In India
This article was originally published in PharmAsia News
Executive Summary
The World Bank says "serious incidents of fraud and corruption" have occurred in India and $570 million worth of health projects funded by the global organization. The Bank said it and the Indian government are investigating whether companies that bid on contracts to supply drugs or other material for the projects were involved or whether Bank or government officials were involved. A two-year-old internal review discovered problems in five projects dealing with AIDS, malaria, tuberculosis and other diseases going back to 1997. (Click here for more - may require a subscription
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.